Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach

被引:0
|
作者
Yara Abukhaled
Kenana Hatab
Mohammad Awadhalla
Hamdan Hamdan
机构
[1] Khalifa University,Department of Physiology and Immunology, College of Medicine, and Health Sciences
[2] Khalifa University,Healthcare Engineering Innovation Center (HEIC)
来源
Journal of Neurology | 2024年 / 271卷
关键词
Down syndrome; Intellectual disability; Morphology; Neuron; Over-inhibition;
D O I
暂无
中图分类号
学科分类号
摘要
The most common genetic cause of intellectual disability is Down syndrome (DS), trisomy 21. It commonly results from three copies of human chromosome 21 (HC21). There are no mutations or deletions involved in DS. Instead, the phenotype is caused by altered transcription of the genes on HC21. These transcriptional variations are responsible for a myriad of symptoms affecting every organ system. A very debilitating aspect of DS is intellectual disability (ID). Although tremendous advances have been made to try and understand the underlying mechanisms of ID, there is a lack of a unified, holistic view to defining the cause and managing the cognitive impairments. In this literature review, we discuss the mechanisms of neuronal over-inhibition, abnormal morphology, and other genetic factors in contributing to the development of ID in DS patients and to gain a holistic understanding of ID in DS patients. We also highlight potential therapeutic approaches to improve the quality of life of DS patients.
引用
收藏
页码:87 / 104
页数:17
相关论文
共 50 条
  • [41] Analyzing energy poverty with Fuzzy Cognitive Maps: A step-forward towards a more holistic approach
    Papada, Lefkothea
    Katsoulakos, Nikolas
    Doulos, Ilias
    Kaliampakos, Dimitris
    Damigos, Dimitris
    ENERGY SOURCES PART B-ECONOMICS PLANNING AND POLICY, 2019, 14 (05) : 159 - 182
  • [42] Clinical segmentation in 22q11.2 deletion syndrome: Cognitive impairments and additional genetic load
    Schmock, H.
    Stevenson, Matt P.
    Hanebaum, S.
    Vangkilde, A.
    Rosengren, A.
    Weinsheimer, S. M.
    Skovby, F.
    Olesen, C.
    Ullum, H.
    Baare, W. F. C.
    Siebner, H. R.
    Didriksen, M.
    Werge, T.
    Olsen, L.
    Jepsen, J. R. M.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2024, 177 : 153 - 161
  • [43] Contributions towards the understanding of the molecular mechanisms underlying preeclampsia by using a transcriptomics approach
    Mostertz, J.
    Reuther, S.
    May, K.
    Hoffman, A.
    Wissuwa, J.
    Grube, M.
    Siegmund, W.
    Kroemer, H. K.
    Homuth, G.
    PLACENTA, 2008, 29 (08) : A81 - A81
  • [44] Do social and cognitive deficits curtail musical understanding?: Evidence from autism and Down syndrome
    Heaton, Pamela
    Allen, Rory
    Williams, Kerry
    Cummins, Omar
    Happe, Francesca
    BRITISH JOURNAL OF DEVELOPMENTAL PSYCHOLOGY, 2008, 26 : 171 - 182
  • [45] Using learning flexibly and remembering after a delay: understanding cognitive dysfunction in adults with Down syndrome
    Roberts, L.
    Richmond, J. L.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2018, 62 (06) : 521 - 531
  • [46] α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome
    Shichiri, Mototada
    Yoshida, Yasukazu
    Ishida, Noriko
    Hagihara, Yoshihisa
    Iwahashi, Hitoshi
    Tamai, Hiroshi
    Niki, Etsuo
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 50 (12) : 1801 - 1811
  • [47] Social-cognitive, physiological, and neural mechanisms underlying emotion regulation impairments: understanding anxiety in autism spectrum disorder
    White, Susan W.
    Mazefsky, Carla A.
    Dichter, Gabriel S.
    Chiu, Pearl H.
    Richey, John A.
    Endick, Thomas H.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2014, 39 : 22 - 36
  • [48] MOLECULAR GENETIC APPROACH TO THE CHARACTERIZATION OF THE DOWN SYNDROME REGION OF CHROMOSOME-21
    MCCORMICK, MK
    SCHINZEL, A
    PETERSEN, MB
    STETTEN, G
    DRISCOLL, DJ
    CANTU, ES
    TRANEBJAERG, L
    MIKKELSEN, M
    WATKINS, PC
    ANTONARAKIS, SE
    GENOMICS, 1989, 5 (02) : 325 - 331
  • [49] Down Syndrome: Genes, Model Systems, and Progress towards Pharmacotherapies and Clinical Trials for Cognitive Deficits
    Busciglio, J.
    Capone, G.
    O'Byran, J. P.
    Gardiner, K. J.
    CYTOGENETIC AND GENOME RESEARCH, 2013, 141 (04) : 260 - 271
  • [50] Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms
    Anderson-Mooney, Amelia J.
    Schmitt, Frederick A.
    Head, Elizabeth
    Lott, Ira T.
    Heilman, Kenneth M.
    BRAIN AND COGNITION, 2016, 104 : 48 - 57